Clinical Trial Update: Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated a large protein therapeutic administered with escalating doses of recombinant human hyaluronidase in rheumatoid arthritis. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Hylenex (hyaluronidase)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED